- Home
- ESP vs CUE Comparison
ESP vs CUE Comparison
Compare ESP & CUE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ESP
- CUE
- Stock Information
- Founded
- ESP 1928
- CUE 2014
- Country
- ESP United States
- CUE United States
- Employees
- ESP N/A
- CUE N/A
- Industry
- ESP Industrial Machinery/Components
- CUE Biotechnology: Pharmaceutical Preparations
- Sector
- ESP Technology
- CUE Health Care
- Exchange
- ESP Nasdaq
- CUE Nasdaq
- Market Cap
- ESP 129.5M
- CUE 48.0M
- IPO Year
- ESP N/A
- CUE 2018
- Fundamental
- Price
- ESP $47.61
- CUE $0.74
- Analyst Decision
- ESP
- CUE Strong Buy
- Analyst Count
- ESP 0
- CUE 3
- Target Price
- ESP N/A
- CUE $3.00
- AVG Volume (30 Days)
- ESP 29.3K
- CUE 323.3K
- Earning Date
- ESP 05-12-2025
- CUE 08-13-2025
- Dividend Yield
- ESP 2.11%
- CUE N/A
- EPS Growth
- ESP 39.20
- CUE N/A
- EPS
- ESP 2.67
- CUE N/A
- Revenue
- ESP $45,965,588.00
- CUE $7,991,000.00
- Revenue This Year
- ESP N/A
- CUE N/A
- Revenue Next Year
- ESP N/A
- CUE $23.84
- P/E Ratio
- ESP $17.72
- CUE N/A
- Revenue Growth
- ESP 29.60
- CUE 13.83
- 52 Week Low
- ESP $20.50
- CUE $0.45
- 52 Week High
- ESP $49.00
- CUE $1.99
- Technical
- Relative Strength Index (RSI)
- ESP 73.32
- CUE 51.10
- Support Level
- ESP $45.94
- CUE $0.65
- Resistance Level
- ESP $48.24
- CUE $0.83
- Average True Range (ATR)
- ESP 1.97
- CUE 0.07
- MACD
- ESP 0.13
- CUE 0.01
- Stochastic Oscillator
- ESP 90.14
- CUE 30.43
About ESP Espey Mfg. & Electronics Corp.
Espey Manufacturing & Electronics Corp designs, develops, tests, and manufactures specialized military and rugged industrial power supplies and transformers for use in harsh or severe environment applications. Its products and solutions include power converters, power conditioning, high-voltage radar, contract manufacturing, custom engineering, and others. The applications of these products include AC and DC locomotives, shipboard power, shipboard radar, airborne power, ground-based radar, and ground mobile power.
About CUE Cue Biopharma Inc.
Cue Biopharma Inc is a clinical-stage biopharmaceutical company. It is developing a novel and proprietary class of biologics drugs for the selective modulation of the human immune system to treat a broad range of cancers and autoimmune disorders. Its objective is to provide patients suffering from cancer and autoimmune diseases with dramatically improved therapeutic outcomes through the platform of biologic drug product candidates. The other products under pipeline are CUE-101 as a Monotherapy, CUE-101 + Pembrolizumab, CUE-102, CUE-103, and others.